Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study Meeting Abstract


Authors: Hauschild, A.; Chapman, P. B.; Robert, C.; Larkin, J.; Haanen, J. B.; Ribas, A.; Hogg, D.; Hamid, O.; Ascierto, P. A.; Testori, A.; Lorigan, P.; Dummer, R.; Sosman, J. A.; Flaherty, K. T.; Wongchenko, M. J.; Yan, Y.; Chang, I.; Coleman, S.; Caro, I.; McArthur, G. A.
Abstract Title: Impact of key prognostic factors on long-term overall survival in BRAF(V600)-mutated metastatic melanoma patients treated with vemurafenib in the BRIM-3 study
Meeting Title: 16th World Congress on Cancers of the Skin (WCCS)
Journal Title: Melanoma Research
Volume: 26
Issue: e-Suppl.
Meeting Dates: 2016 Aug 31-Sep 3
Meeting Location: Vienna, Austria
ISSN: 0960-8931
Publisher: Lippincott Williams & Wilkins  
Date Published: 2016-08-01
Start Page: e39
End Page: e40
Language: English
ACCESSION: WOS:000383560800075
PROVIDER: wos
DOI: 10.1097/CMR.0000000000000285
Notes: Meeting Abstract: P057 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul Chapman
    326 Chapman